INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $105,000 | -54.7% | 92,332 | -10.4% | 0.00% | -66.7% |
| Q4 2021 | $232,000 | -37.6% | 103,021 | -5.3% | 0.00% | -25.0% |
| Q3 2021 | $372,000 | +6.6% | 108,741 | -6.9% | 0.00% | +33.3% |
| Q2 2021 | $349,000 | +252.5% | 116,761 | +84.7% | 0.00% | +200.0% |
| Q3 2016 | $99,000 | +7.6% | 63,217 | -9.0% | 0.00% | 0.0% |
| Q2 2016 | $92,000 | – | 69,463 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |